Industry Insights
-
6 Pillars To Support Community Hospitals' First Steps Into Clinical Trials
12/22/2025
Discover six pillars community hospitals can leverage to make a compelling case for clinical trials: dedicated infrastructure, community engagement, technology platforms, financial support, strategic partnerships, and physician engagement.
-
Most Ex-U.S. Countries Can't Access The Medicines They Help Study
12/19/2025
When a country hosts a clinical trial, we assume patients there will eventually benefit from the therapy they helped test. Research Jennifer E. Miller, Ph.D., says that's not often the case.
-
More Patient Insight — And Funding— Needed To Advance Preeclampsia Research
12/18/2025
Preeclampsia Foundation’s Laney Poye discusses the urgent need for sustained preeclampsia research funding, patient-informed trial design, and stronger partnerships between advocacy groups and biopharma.
-
What Is Win Ratio, And How Can It Be Used In Rare Disease Research?
12/17/2025
Amber Salzman, CEO of Epicrispr Biotechnologies, explains how applying the win ratio in facioscapulohumeral muscular dystrophy (FSHD) could transform the way researchers evaluate therapeutic impact, enhance statistical efficiency, and improve trial design.
-
Adaptive Trial Design Is Changing Oncology And Hematology Clinical Trials
12/16/2025
Pfizer Global Development Lead, Clinical Development Oncology & Hematology, Shreya Badhrinarayanan, MD, explains how adaptive trials, enriched by AI and better data integration, are transforming oncology and hematology clinical research.
-
Poland: An Underestimated Clinical Trials Powerhouse
12/15/2025
Poland is not “one of the good options” or “an interesting emerging market," says Tomasz Szelag, head of clinical operations, Ryvu Therapeutics. Rather, it should be one of the first places sponsors look to run their clinical trials.
-
Can't-Miss Advice On Selecting Your First AI-Enabled Vendor
12/12/2025
Quarles & Brady 's Simone Colgan Dunlap and Meghan O’Connor offer actionable guidance to help sponsor companies make informed, strategic choices in an evolving AI market.
-
Hidden Costs Of Data Cleaning: Build Quality At The Source
12/11/2025
Hidden costs from downstream data cleaning slow trials and raise risk. Explore why building quality at the source accelerates timelines, reduces errors, and gives sponsors a competitive edge.
-
Aligning Global Standards For ICH E6(R3) And Artificial Intelligence
12/11/2025
Global standards and AI are transforming clinical research. Learn why mastering ICH E6(R3) and risk-based compliance is critical for data integrity and future success.
-
Securing Sponsor Reimbursement For CRIO Fees
12/11/2025
Gain sponsor approval by positioning technology as key to streamlined workflows, compliance, and patient safety — reducing risk and improving collaboration. Explore strategies now.